Pharmaceutical Research & Consulting, Inc. is conducting a research study with an investigational medication for adults with asthma. If you are between the ages of 18 to 75 and have had asthma for 6 months or longer, you may be eligible to participate.
Qualified participants receive:
• Study medicine and study-related office visits at no cost
• Study-related ECG, lung function tests, and lab work at no cost
• Financial compensation up to $550 for qualifying participants
• Evaluation and supervision by board-certified allergists Dr. Gary Gross and Dr. Michael Ruff